India's first dengue virus mapping shows all four serotypes circulating in eight states. This finding could influence the ...

Monsoon often brings relief from the heat, but it also marks the return of one of India's biggest seasonal health concerns: ...

CDSCO has cleared Takeda's QDENGA dengue vaccine for people aged 4–60 years, marking a major milestone as India steps up its ...

The approval of QDENGA, a tetravalent dengue vaccine, marks progress in India’s fight against dengue. Local production by ...

Qdenga could be responsible for enhancing dengue in children who have not had an infection yet in their lives. In such cases, ...

India's dengue virus is evolving dangerously, with multiple strains circulating, increasing severe illness risks and ...

India approves QDENGA, its first dengue vaccine. This milestone is only the start of a larger public health challenge.

India has approved its first dengue vaccine, authorizing the use of Japanese drugmaker Takeda's Qdenga jab, the Health ...

ICMR's first nationwide study found that all four dengue virus strains were circulating in eight Indian states, raising ...

India has approved Qdenga, its first dengue vaccine, for people aged four to 60. Here is how it works, its effectiveness, safety and availability.

India approves QDENGA, its first dengue vaccine, offering protection against all four dengue virus strains for people aged 4 ...

The surveillance found that multiple dengue serotypes were circulating across the regions studied, indicating increasing ...